Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NEO/BMND stock hub

NEO/BMND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEO/BMNDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.7M

Cboe Canada

Market data

Live price

Current market quote for this ticker.

Current price

NEO/BMND

In the news

Latest news · NEO/BMND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEO/BMND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

125

Groups with data

Currency

USD

Showing 125 of 125 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	-4%
Employees Change Percent	-44.44
Enterprise value	CAD 13.7M
Exchange	Cboe Canada
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA0907021012
Last refreshed	2026-05-10
Market cap	CAD 12.7M
Price	CAD 0.19
Price currency	CAD
Sector	Healthcare
Sic	2833
Symbol	neo/BMND
Website	https://www.biomindlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.2%
EV Earnings	-11.72x
P/B ratio	-5.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -1.2M
ROA	-2,568.8
Roa5y	-814.8
ROCE	48.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-47.17%
Cagr3y	-39.12%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 49
Cash	CAD 49
Current Assets	CAD 49.21
Current Liabilities	CAD 2.4M
Debt	CAD 998,838
Equity	CAD -2.4M
Interest Coverage	-12.32
Liabilities	CAD 2.4M
Long Term Assets	CAD -0.21
Long Term Liabilities	CAD 7,064
Net Cash	CAD -998,788
Net Cash By Market Cap	CAD -7.88
Tangible Book Value	CAD -2.4M
Tangible Book Value Per Share	CAD -0.03
WACC	42.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0
Net Working Capital	CAD -1.4M
Quick ratio	0
Working Capital	CAD -2.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.87%
Dividend per share	CAD 0
Last Dividend	CAD 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-47.14%
200-day SMA	0.34
3Y total return	-77.44%
50-day SMA	0.22
50-day SMA vs 200-day SMA	50under200
All Time High	1.9
All Time High Change	-90.26%
All Time High Date	2021-07-29
All Time Low	0.01
All Time Low Change	1,750%
All Time Low Date	2026-03-20
ATR	0.06
Beta	7.51
Ch YTD	2.78
High	0.19
High52	0.32
High52 Date	2025-12-15
High52ch	-42.19%
Low	0.19
Low52	0.01
Low52 Date	2026-03-20
Low52ch	1,750%
Ma50ch	-14.75%
Price vs 200-day SMA	-45.46%
RSI	47.11
RSI Monthly	40.92
RSI Weekly	43.93
Sharpe ratio	2.03x
Sortino ratio	7.81
Total Return	-1.87%
Tr YTD	2.78
Tr1m	-5.13%
Tr1w	23.33%
Tr3m	94.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,405,582%
Net Borrowing	118,031.1
Shares Insiders	36.31%
Shares Qo Q	0%
Shares Yo Y	1.87%
Short Ratio	0.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	7,906x
Bv Per Share	-0.03
Ch1m	-5.13
Ch1w	23.33
Ch1y	-47.14
Ch3m	94.74
Ch3y	-77.44
Ch6m	-47.14
Change	0%
Change From Open	0
Close	0.19
Days Gap	0
Depreciation Amortization	3,048.5
Earnings Date	2026-05-14
EBIT	CAD -1.2M
EBITDA	CAD -1.2M
EPS	CAD -0.02
F Score	1
Financing CF	118,383
Fiscal Year End	December
Is Primary Listing	0
Last Earnings Date	2025-10-30
Last Report Date	2025-12-31
Ma150	0.38
Ma150ch	-51.37%
Ma20	0.15
Ma20ch	20.92%
Net CF	-152
Next Earnings Date	2026-05-14
Open	0.19
Price Date	2026-05-07
Relative Volume	0.25x
Share Based Comp	578,921
Tr6m	-47.14%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NEO/BMND pay a dividend?

Capital-return profile for this ticker.

Performance

NEO/BMND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NEO/BMND?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+36.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NEO/BMND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

-45.5%

50/200-day relationship not available

Beta (5Y)

7.51

More volatile than the market

Sharpe ratio

2.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEO/BMND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current neo/BMND stock rating?

neo/BMND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full neo/BMND analysis?

The full report lives at /stocks/neo/BMND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for neo/BMND?

The latest report frames neo/BMND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the neo/BMND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.